PMC:7116472 / 31732-32585 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"456","span":{"begin":183,"end":191},"obj":"Species"},{"id":"457","span":{"begin":642,"end":650},"obj":"Species"},{"id":"458","span":{"begin":789,"end":797},"obj":"Chemical"},{"id":"459","span":{"begin":202,"end":211},"obj":"Disease"},{"id":"460","span":{"begin":254,"end":263},"obj":"Disease"},{"id":"461","span":{"begin":393,"end":402},"obj":"Disease"},{"id":"462","span":{"begin":404,"end":413},"obj":"Disease"},{"id":"463","span":{"begin":500,"end":509},"obj":"Disease"},{"id":"464","span":{"begin":572,"end":581},"obj":"Disease"},{"id":"465","span":{"begin":700,"end":705},"obj":"Disease"}],"attributes":[{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"Tax:9606"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"Tax:9606"},{"id":"A458","pred":"tao:has_database_id","subj":"458","obj":"MESH:D013256"},{"id":"A459","pred":"tao:has_database_id","subj":"459","obj":"MESH:D003643"},{"id":"A460","pred":"tao:has_database_id","subj":"460","obj":"MESH:D003643"},{"id":"A461","pred":"tao:has_database_id","subj":"461","obj":"MESH:D003643"},{"id":"A462","pred":"tao:has_database_id","subj":"462","obj":"MESH:D003643"},{"id":"A463","pred":"tao:has_database_id","subj":"463","obj":"MESH:D003643"},{"id":"A464","pred":"tao:has_database_id","subj":"464","obj":"MESH:D011014"},{"id":"A465","pred":"tao:has_database_id","subj":"465","obj":"MESH:D003643"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A key aim of risk stratification is to support clinical management decisions. Four risk classes were identified and showed similar adverse outcome rates across the validation cohort. Patients with a 4C Mortality Score falling within the low risk groups (mortality rate 1%) might be suitable for management in the community, while those within the intermediate risk group were at lower risk of mortality (mortality rate 10%; 22% of the cohort) and might be suitable for ward level monitoring. Similar mortality rates have been identified as an appropriate cut-off value in pneumonia risk stratification scores (CURB-65 and PSI).2122 Meanwhile patients with a score of 9 or higher were at high risk of death (around 40%), which could prompt aggressive treatment, including the initiation of steroids49 and early escalation to critical care if appropriate."}

{"project":"LitCovid-sentences","denotations":[{"id":"T198","span":{"begin":0,"end":77},"obj":"Sentence"},{"id":"T199","span":{"begin":78,"end":182},"obj":"Sentence"},{"id":"T200","span":{"begin":183,"end":491},"obj":"Sentence"},{"id":"T201","span":{"begin":492,"end":853},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A key aim of risk stratification is to support clinical management decisions. Four risk classes were identified and showed similar adverse outcome rates across the validation cohort. Patients with a 4C Mortality Score falling within the low risk groups (mortality rate 1%) might be suitable for management in the community, while those within the intermediate risk group were at lower risk of mortality (mortality rate 10%; 22% of the cohort) and might be suitable for ward level monitoring. Similar mortality rates have been identified as an appropriate cut-off value in pneumonia risk stratification scores (CURB-65 and PSI).2122 Meanwhile patients with a score of 9 or higher were at high risk of death (around 40%), which could prompt aggressive treatment, including the initiation of steroids49 and early escalation to critical care if appropriate."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T23","span":{"begin":572,"end":581},"obj":"Phenotype"}],"attributes":[{"id":"A23","pred":"hp_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"A key aim of risk stratification is to support clinical management decisions. Four risk classes were identified and showed similar adverse outcome rates across the validation cohort. Patients with a 4C Mortality Score falling within the low risk groups (mortality rate 1%) might be suitable for management in the community, while those within the intermediate risk group were at lower risk of mortality (mortality rate 10%; 22% of the cohort) and might be suitable for ward level monitoring. Similar mortality rates have been identified as an appropriate cut-off value in pneumonia risk stratification scores (CURB-65 and PSI).2122 Meanwhile patients with a score of 9 or higher were at high risk of death (around 40%), which could prompt aggressive treatment, including the initiation of steroids49 and early escalation to critical care if appropriate."}